FINANCE
-
Here’s Meridian Hedged Equity Fund’s Updates on Liberty Broadband Corporation (LBRDK)
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter…
Read More » -
This investor, 25, built real wealth once he quit turning over rocks hoping to find the next Tesla. Here’s how
The thrill of finding the next hot tech stock or cryptocurrency can feel invigorating, but tracking down that golden goose…
Read More » -
Capture the Best of Telegram Economics at a Steep Discount – Initiation Report
Download the Complete Report Here By Brandon Hornback Seeking a stock-market bargain to brighten the holidays? Savvy investors should consider…
Read More » -
The Best Dividend Stocks for Retirement Portfolios in 2026
Ilyas nasrulloh / Shutterstock.com Procter & Gamble leads with a 68-year dividend growth streak and 3.31% yield backed by 26%…
Read More » -
Inside Stellantis CEO’s ’emergency room’ rush to recapture market share
By Giulio Piovaccari, Nora Eckert and Gilles Guillaume MILAN/DETROIT/PARIS, Dec 11 (Reuters) – New Stellantis CEO Antonio Filosa is prioritising…
Read More » -
Do You Believe in the Growth Potential of SAP (SAP)?
Polen Capital, an investment management company, released its third-quarter 2025 “Polen International Growth Strategy” investor letter. A copy of the…
Read More » -
This AI ETF Could Dominate for Decades to Come
Most companies are still experimenting with or just piloting AI in their businesses, creating a lot of long-term growth potential…
Read More » -
Should You Be Confident in Kirby Corporation (KEX)?
Meridian Funds, managed by ArrowMark Partners, released its third-quarter 2025 investor letter for the “Meridian Small Cap Growth Fund.” A…
Read More » -
You probably shouldn’t wait till 70 to claim Social Security. Here’s math to open your eyes (but nobody likes to show)
On paper, it seems rather obvious that the best way to optimize your retirement is to delay claiming Social Security…
Read More » -
SK bolsters oncology pipeline in radiopharmaceutical licensing deal
SK Biopharmaceuticals has in-licensed its second radiopharmaceutical – this time from a US-based academic organisation – in a bid to…
Read More »
